Literature DB >> 7549561

Protective effects of propranolol on experimentally head-injured mouse brains.

M Y Liu1.   

Abstract

Catecholamines have a deleterious effect on the traumatized brain. Propranolol, a beta-adrenergic blocker, can act on the vasomotor centers within the hypothalamus and brain stem to reduce the activity of the sympathetic nerves and the cerebral metabolic need for oxygen and glucose. This study investigated the effects of racemic (d,l) propranolol on the neurologic recovery of mice with head-injuries. Male BALB-C mice (n = 110) received a 1,100 g-cm head injury from a 50 g weight dropped from a height of 22 cm resulting in immediate loss of consciousness in all animals and some deaths. The survivors were divided into treatment (n = 46) and placebo (n = 45) groups. The treatment group received an intraperitoneal injection of propranolol 2.5mg/kg immediately after the head injury. The placebo group received the same amount of 0.9% normal saline by injection in the same time interval. Neurologic status was evaluated 1 hour after injury. A group of 50 mice without head injury was also tested to evaluate the performance of normal mice. All three groups of mice were then decapitated. Mice with depressed fractures of the skull (n = 1) or intracranial hematomas (n = 1) after head injury were excluded from the study. Small pieces of brain parenchyma were used to check the water content by gravimetric method. The treatment group showed better neurologic recovery than the placebo group by both the string test scoring system and grip test time. The brain edema was significantly reduced at the temporal lobes in the treatment group as compared to the placebo group.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7549561

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  12 in total

Review 1.  β-Blockade use for Traumatic Injuries and Immunomodulation: A Review of Proposed Mechanisms and Clinical Evidence.

Authors:  Tyler J Loftus; Philip A Efron; Lyle L Moldawer; Alicia M Mohr
Journal:  Shock       Date:  2016-10       Impact factor: 3.454

2.  The Effect of β-blockade on Survival After Isolated Severe Traumatic Brain Injury.

Authors:  Shahin Mohseni; Peep Talving; Eric P Thelin; Göran Wallin; Olle Ljungqvist; Louis Riddez
Journal:  World J Surg       Date:  2015-08       Impact factor: 3.352

Review 3.  Influence of alcohol on mortality in traumatic brain injury.

Authors:  Razvan C Opreanu; Donald Kuhn; Marc D Basson
Journal:  J Am Coll Surg       Date:  2010-06       Impact factor: 6.113

Review 4.  Current Clinical Trials in Traumatic Brain Injury.

Authors:  Zubair Ahmed
Journal:  Brain Sci       Date:  2022-04-21

5.  Propranolol protects cerebral autoregulation and reduces hippocampal neuronal cell death through inhibition of interleukin-6 upregulation after traumatic brain injury in pigs.

Authors:  William M Armstead; Monica S Vavilala
Journal:  Br J Anaesth       Date:  2019-09-18       Impact factor: 9.166

Review 6.  Beta blockers for acute traumatic brain injury: a systematic review and meta-analysis.

Authors:  Aziz S Alali; Victoria A McCredie; Eyal Golan; Prakesh S Shah; Avery B Nathens
Journal:  Neurocrit Care       Date:  2014-06       Impact factor: 3.210

7.  Propranolol and Mesenchymal Stromal Cells Combine to Treat Traumatic Brain Injury.

Authors:  Daniel J Kota; Karthik S Prabhakara; Alexandra J van Brummen; Supinder Bedi; Hasen Xue; Bryan DiCarlo; Charles S Cox; Scott D Olson
Journal:  Stem Cells Transl Med       Date:  2015-11-19       Impact factor: 6.940

8.  Decreasing adrenergic or sympathetic hyperactivity after severe traumatic brain injury using propranolol and clonidine (DASH After TBI Study): study protocol for a randomized controlled trial.

Authors:  Mayur B Patel; John W McKenna; JoAnn M Alvarez; Ayaka Sugiura; Judith M Jenkins; Oscar D Guillamondegui; Pratik P Pandharipande
Journal:  Trials       Date:  2012-09-26       Impact factor: 2.279

9.  Beta blockade in TBI: Dose-dependent reductions in BBB leukocyte mobilization and permeability in vivo.

Authors:  Alfonso J Lopez; Mohamed ElSaadani; Christina L Jacovides; Anastasia Georges; Matthew C Culkin; Syed Ahmed; Monisha A Kumar; Lewis J Kaplan; Douglas H Smith; Jose L Pascual
Journal:  J Trauma Acute Care Surg       Date:  2022-01-18       Impact factor: 3.697

Review 10.  Critical Evaluation of the Lund Concept for Treatment of Severe Traumatic Head Injury, 25 Years after Its Introduction.

Authors:  Per-Olof Grände
Journal:  Front Neurol       Date:  2017-07-04       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.